A detailed history of Tower Research Capital LLC (Trc) transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,304 shares of ALDX stock, worth $15,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,304
Previous 9,629 65.69%
Holding current value
$15,826
Previous $31,000 45.16%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $6.32 $20,176 - $39,974
-6,325 Reduced 65.69%
3,304 $17,000
Q2 2024

Aug 13, 2024

BUY
$3.25 - $4.72 $29,692 - $43,121
9,136 Added 1853.14%
9,629 $31,000
Q1 2024

May 15, 2024

SELL
$2.77 - $4.22 $60,036 - $91,464
-21,674 Reduced 97.78%
493 $1,000
Q4 2023

Feb 13, 2024

BUY
$1.47 - $6.06 $29,788 - $122,799
20,264 Added 1064.84%
22,167 $77,000
Q3 2023

Nov 14, 2023

SELL
$6.11 - $8.16 $14,749 - $19,698
-2,414 Reduced 55.92%
1,903 $12,000
Q2 2023

Aug 14, 2023

BUY
$7.11 - $11.89 $30,629 - $51,222
4,308 Added 47866.67%
4,317 $36,000
Q1 2023

May 09, 2023

BUY
$5.77 - $9.93 $51 - $89
9 New
9 $0
Q3 2022

Nov 10, 2022

BUY
$3.8 - $7.74 $25,665 - $52,275
6,754 New
6,754 $36,000
Q2 2022

Aug 15, 2022

SELL
$2.43 - $4.85 $46,145 - $92,101
-18,990 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$3.25 - $5.17 $23,227 - $36,949
7,147 Added 60.35%
18,990 $85,000
Q4 2021

Feb 14, 2022

SELL
$3.5 - $9.63 $28,588 - $78,657
-8,168 Reduced 40.82%
11,843 $47,000
Q3 2021

Nov 15, 2021

BUY
$7.94 - $11.31 $139,839 - $199,191
17,612 Added 734.14%
20,011 $175,000
Q2 2021

Aug 16, 2021

BUY
$10.44 - $14.85 $9,114 - $12,964
873 Added 57.21%
2,399 $27,000
Q1 2021

May 17, 2021

SELL
$6.53 - $14.42 $5,596 - $12,357
-857 Reduced 35.96%
1,526 $18,000
Q4 2020

Feb 16, 2021

BUY
$6.31 - $8.13 $3,621 - $4,666
574 Added 31.73%
2,383 $16,000
Q3 2020

Nov 16, 2020

SELL
$4.0 - $7.53 $2,500 - $4,706
-625 Reduced 25.68%
1,809 $13,000
Q2 2020

Aug 13, 2020

BUY
$1.97 - $5.05 $4,794 - $12,291
2,434 New
2,434 $10,000
Q1 2020

May 15, 2020

SELL
$1.62 - $6.4 $11,309 - $44,678
-6,981 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$4.73 - $7.98 $22,174 - $37,410
4,688 Added 204.45%
6,981 $41,000
Q3 2019

Nov 05, 2019

BUY
$4.41 - $6.12 $9,234 - $12,815
2,094 Added 1052.26%
2,293 $12,000
Q2 2019

Aug 13, 2019

BUY
$6.0 - $9.0 $1,194 - $1,791
199 New
199 $1,000
Q1 2019

May 14, 2019

SELL
$7.14 - $9.85 $15,286 - $21,088
-2,141 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$7.26 - $13.29 $12,944 - $23,696
1,783 Added 498.04%
2,141 $18,000
Q3 2018

Nov 13, 2018

SELL
$6.8 - $14.35 $11,104 - $23,433
-1,633 Reduced 82.02%
358 $5,000
Q2 2018

Aug 15, 2018

BUY
$6.95 - $9.18 $6,519 - $8,610
938 Added 89.08%
1,991 $15,000
Q1 2018

May 15, 2018

BUY
$6.55 - $8.9 $6,739 - $9,158
1,029 Added 4287.5%
1,053 $8,000
Q4 2017

Feb 09, 2018

SELL
$5.7 - $7.75 $18,006 - $24,482
-3,159 Reduced 99.25%
24 $0
Q3 2017

Nov 14, 2017

BUY
$3.9 - $10.8 $12,413 - $34,376
3,183
3,183 $23,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.